MetaCap

Editas Medicine Statistics

NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.64-0.07 (-4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Editas Medicine by the numbers

Editas Medicine has a market capitalization of $253.1 million based on 154.34M shares outstanding. With trailing EPS of $-0.54, Editas Medicine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.0% below its 50-day average and 39.2% below its 200-day average.

Average daily trading volume is 2.63M shares, or about $4.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EDIT valuation vs. peer median

EDIT compared with the median of 8 peer companies
MetricEDITPeer medianDifference
Market cap$253.12M$255.00M-1%
Avg. volume2.63M885.38K+197%

Peer median across 8 companies: SABS, EIKN, OCGN, LXEO, PLX, AUTL, AGMB, KYTX.

Valuation

Market cap
$253.12M
Price / sales (latest FY)
6.25
EPS (TTM)
$-0.54

Price and trading

Previous close
1.71
Open
1.69
Day range
1.63 – 1.78
52-week range
1.63 – 3.94
52-week change
-32.23%
Beta
—
Volume
2.68M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
253.12M
Forward Pe
-2.26
Eps
-0.54
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.94
Week52 Low
1.63
Avg Volume
2.63M
Shares Outstanding
154.34M
Ma50
2.52
Ma200
2.70
Earnings Date
Nov 9, 2026
Pct From52w High
-58.38%
Pct From52w Low
0.61%

Related